Western reliance on China's antibiotics poses a looming healthcare crisis

A new report has warned that Britain and its Western allies face a severe risk from their reliance on China for vital antibiotics. The study highlights how just a handful of Chinese firms control the global supply chain, leaving healthcare systems vulnerable to sudden shortages. Experts now urge governments to rebuild domestic production to avoid a potential crisis. China dominates the antibiotics market, producing up to 90% of the key ingredients used in Britain and the US. Only seven factories in China manufacture the core compound for penicillin, creating a dangerous bottleneck. If these sites fail—whether through industrial accidents, export bans, or political tensions—supplies to the West could collapse within weeks.

India, which provides most antibiotics to Britain and America, depends on China for 91.5% of its raw materials. The top four Chinese suppliers alone account for over half of India’s imports. This heavy reliance means any disruption in China would quickly starve Western hospitals of essential drugs. The report warns that China could weaponise this dependency, even outside wartime. By restricting supplies to India, Beijing could indirectly cut off the UK, Europe, and the US from life-saving medications. In a military conflict, China could immediately sever medical supplies to Western forces and hospitals, crippling their ability to respond. Years of price suppression by Chinese manufacturers have driven Western producers out of the market. Today, just one penicillin plant remains in Austria, leaving Europe with almost no domestic capacity. The report calls for urgent action, including new manufacturing sites outside China and India, and integrating antibiotic supply security into NATO’s defence planning.

The findings reveal a critical weakness in Western healthcare systems. Without rapid investment in domestic production, Britain and its allies remain exposed to supply shocks from China. The report stresses that building independent supply chains is now a matter of national security.